174 related articles for article (PubMed ID: 36205138)
1. New insight into the role of PTCH1 protein in serous ovarian carcinomas.
Karin-Kujundzic V; Covarrubias-Pinto A; Skrtic A; Vranic S; Serman L
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36205138
[TBL] [Abstract][Full Text] [Related]
2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
3. Dishevelled family proteins in serous ovarian carcinomas: a clinicopathologic and molecular study.
Karin-Kujundzic V; Kardum V; Sola IM; Paic F; Skrtic A; Skenderi F; Serman A; Nikuseva-Martic T; Vranic S; Serman L
APMIS; 2020 Mar; 128(3):201-210. PubMed ID: 31755579
[TBL] [Abstract][Full Text] [Related]
4. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas.
Kardum V; Karin V; Glibo M; Skrtic A; Martic TN; Ibisevic N; Skenderi F; Vranic S; Serman L
Ann Diagn Pathol; 2017 Dec; 31():45-49. PubMed ID: 29146058
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
[TBL] [Abstract][Full Text] [Related]
7. Patched 1 expression in Merkel cell carcinoma.
Gambichler T; Dreißigacker M; Kasakovski D; Skrygan M; Wieland U; Silling S; Gravemeyer J; Melior A; Cherouny A; Stücker M; Stockfleth E; Sand M; Becker JC
J Dermatol; 2021 Jan; 48(1):64-74. PubMed ID: 33180347
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium.
van der Ploeg P; Uittenboogaard A; Bosch SL; van Diest PJ; Wesseling-Rozendaal YJW; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ
Gynecol Oncol; 2022 Apr; 165(1):114-120. PubMed ID: 35123772
[TBL] [Abstract][Full Text] [Related]
9. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
10. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
Morency E; Leitao MM; Soslow RA
Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
[TBL] [Abstract][Full Text] [Related]
11. A low-grade ovarian carcinoma case with coincident LOH of PTCH1 and BRCA1, and a mutation in BRCA1.
Maurac I; Sabol M; Musani V; Car D; Ozretic P; Kalafatic D; Oreskovic S; Babic D; Levanat S
Int J Gynecol Pathol; 2012 May; 31(3):264-71. PubMed ID: 22498944
[TBL] [Abstract][Full Text] [Related]
12. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
13. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B
Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196
[TBL] [Abstract][Full Text] [Related]
14. Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
Gambaro K; Quinn MC; Cáceres-Gorriti KY; Shapiro RS; Provencher D; Rahimi K; Mes-Masson AM; Tonin PN
BMC Cancer; 2015 Mar; 15():135. PubMed ID: 25886299
[TBL] [Abstract][Full Text] [Related]
15. New insights into the GDF9-Hedgehog-GLI signaling pathway in human ovaries: from fetus to postmenopause.
Asiabi P; David C; Camboni A; Marbaix E; Dolmans MM; Amorim CA
J Assist Reprod Genet; 2021 Jun; 38(6):1387-1403. PubMed ID: 33772413
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer.
Song IH; Kim KR; Lim S; Kim SH; Sung CO
Pathol Res Pract; 2018 Oct; 214(10):1564-1571. PubMed ID: 30082157
[TBL] [Abstract][Full Text] [Related]
17. Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M; Yang RZ; Kang EY; Al-Shamma Z; Cook LS; Kinloch M; Carey MS; Hopkins L; Nelson GS; McManus KJ; Vizeacoumar FS; Vizeacoumar FJ; Freywald A; Fu Y; Reuss DE; Lee CH
Gynecol Oncol; 2023 Nov; 178():80-88. PubMed ID: 37820398
[TBL] [Abstract][Full Text] [Related]
18. [Serous ovarian tumors].
Diebold J
Pathologe; 2014 Jul; 35(4):314-21. PubMed ID: 24916775
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
20. Decreased Eph receptor‑A1 expression is related to grade in ovarian serous carcinoma.
Jin Y; Zou Y; Wan L; Lu M; Liu Y; Huang G; Wang J; Xi Q
Mol Med Rep; 2018 Apr; 17(4):5409-5415. PubMed ID: 29393455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
